TipHub

₹5.23

▼ -0.27 -4.91%

As of 29 Jul 2026 · delayed

BSE Listed

GSM · GSM 0
What does GSM · GSM 0 mean?
BSE · Graded Surveillance Measure (GSM 0)GSM targets fundamentally weak companies whose price doesn't square with their financials (tiny net worth or negative/extreme P/E). Practical meaning: the exchange doubts the price is backed by the business. Stage 0 is a watchlist; each higher stage makes the stock progressively harder to trade — tighter bands, full upfront margin, weekly-only trading, and at Stage IV no upward price movement at all. Exiting requires a quarterly review finding the criteria no longer met.Criteria: Shortlisted on objective financial parameters — net worth, net fixed assets, price-to-earnings multiple and market capitalisation. Stage 0 = base surveillance watchlist (identified under GSM, no graded price restriction yet); Stages I–VI add escalating curbs (price band, 100% margin, periodic call auction, settlement on a gross/trade-for-trade basis, no upward price movement).

Boston Commerce Limited (531458)

Volume: 74Avg Vol 1W: 175Avg Vol 1M: 8,38852W Range:₹4.77₹10.95
BSE www.bostonbiosystemltd.com AI Report
Key Ratios
Checked just now
Market Cap₹4 Cr
Current Price₹5.23
Previous Close₹5.5
High / Low (52w)₹10.95 / ₹4.77
Volume74
Avg Vol (1W)175
Avg Vol (1M)8,388
Stock P/E—
Book Value₹7.6
Dividend Yield0%
ROE-10.91%
ROA-7.87%
Revenue (TTM)—
Revenue Growth—
Profit Margin-120.83%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0
P/B0.69
Debt / Equity0.51
50 DMA₹6.13
200 DMA₹7.12
Day change-4.91%
SurveillanceGSM · GSM 0
Price Chart
₹5.23▼ 33.63% · 1Y
₹10₹53.5L
2025-07-30
2026-07-29

20-day avg volume: 7K shares

Pros
  • Company is almost debt-free.
  • Stock trades below its book value.
Cons
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2015Mar 2016Mar 2017Mar 2018Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹0 Cr₹1 Cr₹1 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr
EPS0000-0-0-0.2-0.78
Balance Sheet
MetricMar 2015Mar 2016Mar 2017Mar 2018Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹7 Cr₹9 Cr₹9 Cr₹10 Cr₹11 Cr₹11 Cr₹11 Cr₹15 Cr
Total Liabilities₹0 Cr₹2 Cr₹3 Cr₹3 Cr₹4 Cr₹4 Cr₹4 Cr₹9 Cr
Equity₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹6 Cr₹6 Cr
Total Debt————————
Cash Flow
MetricMar 2022Mar 2023Mar 2024Mar 2025
Operating₹0 Cr₹0 Cr₹0 Cr₹-5 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Financing₹0 Cr₹0 Cr₹0 Cr₹5 Cr
Free Cash Flow₹0 Cr₹0 Cr₹0 Cr₹-5 Cr
Shareholding
Promoter 2.14% Institutions 1.7% Public 96.15%
Efficiency & Working Capital
ROCE0.2%
Interest Coverage0
Dividend Payout—
Debtor Days—
Inventory Days—
Payable Days—
Cash Conversion Cycle—
Working Capital Days—
Shareholding Details

As of 2026-06-30

Promoter2.1%
FII0%
DII1.7%
Institutions1.7%
Public96.2%
Promoter Pledge0%
No. of Shareholders1,447
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters2.1%2.1%2.1%2.1%2.1%2.1%2.1%2.1%2.1%2.1%2.1%2.1%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%1.7%1.7%
Public97.9%97.9%97.9%97.9%97.9%97.9%97.9%97.9%97.9%97.9%96.2%96.2%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders1,1411,1411,1411,1411,1411,1411,1471,2951,3851,4101,4081,447
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Mayank DoshiPublic Shareholding2.6%1,81,971
Manisha H DabhiPublic Shareholding2.2%1,52,850
Sangita Pradyuman ShahPublic Shareholding2.1%1,50,000
Jyotshna Jagdishchandra ShahShareholding of Promoter and Promoter Group2.1%1,50,000
Unicorn FundPublic Shareholding1.7%1,19,240
Amarish Jagmohan ShahPublic Shareholding1.7%1,18,372
Suryansh Stock & Shares Pvt LtdPublic Shareholding1.4%97,598
Rajesh Kumar GargPublic Shareholding1.3%93,000
Hetal Babulal ThakorePublic Shareholding1.2%85,000
Anand GargPublic Shareholding1.2%81,000
Jay Hasmukh FofaniPublic Shareholding1.1%78,952
Dazzel Confindive LtdPublic Shareholding1.1%78,304
Bhavna Hasmukh FofaniPublic Shareholding1.1%77,518
Amit Kumar GargPublic Shareholding1.1%78,000
Chhaganlal Keshavlal PatelPublic Shareholding1.1%75,000
Tikamchand GargPublic Shareholding1.1%74,155
Manubhai ShahPublic Shareholding1%70,500
Dr. Ushma B. VaishnavShareholding of Promoter and Promoter Group0%10
Dr. Bakul J. VaishnavShareholding of Promoter and Promoter Group0%10
Board of Directors
NameDesignationYear
Ghanshyam Dhananjay GavaliExecutive Director & MD2025
Yash Arun ChaudharyIndependent Non Exe. Director2025
Aashish Shrirang DharmadhikariIndependent Non Exe. Director2025
Swati Suresh DhadveIndependent Non Exe. Director2025
Mandeep KaurCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
TRADING₹1 Cr100%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10877
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-07Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000000
2025000000
2025000000
Company Information
Incorporated1995
AuditorNahar V & Co/Sunit M Chhatbar & Co
Investor Email[email protected]
🌐 www.bostonbiosystemltd.com ↗

📍 17/B 4th Floor Mirzapur, Sandesh Commerical Complex, Ahmedabad, Gujarat, 380001

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Aion Tech SolutionsLyons Corporate Market Ltd.Vardhman Concrete LimitedGRM OverseasPolylink Polymers (India) Ltd.Minaxi Textiles Ltd.Continental Controls Ltd.Global Infratech & Finance Ltd.Nouveau Global Ventures LimitedDuke Offshore Ltd.Cybele Industries Ltd.Filmcity Media Ltd.All “53” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search